Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
24
01
2019
accepted:
30
04
2019
entrez:
16
5
2019
pubmed:
16
5
2019
medline:
21
1
2020
Statut:
epublish
Résumé
Determining mycobacterial burden is important in assessing severity of disease, evaluating infectiousness and predicting patient treatment outcomes. Mycobacterial burden assessed by smear microscopy grade and time to culture positivity is clearly interpretable by most physicians. GeneXpert (Xpert) has been recommended by WHO as a first line tuberculosis (TB) diagnostic test as an alternative to smear microscopy. Xpert gives cycle threshold (Ct) values as a potential measure for mycobacterial burden. For physicians to clearly interpret Ct values as measures of mycobacterial burden, this study compared the Xpert quantification capabilities with those of smear microscopy and culture. The study also determined a linear relationship between Xpert Ct values and MGIT culture time to positivity (MGIT-TTP) and associated factors. A cut off Ct value which best predicts smear positivity was also determined using the Receiver Operator Curve analysis method. Excluding missing results and rifampicin resistant TB cases, a moderately strong correlation of 0.55 between Xpert Ct value and smear grade was obtained. A weak correlation of 0.37 was obtained between Xpert Ct values and MGIT time to positivity while that between Xpert Ct values and LJ culture was 0.34. The Xpert Ct values were found to increase by 2.57 for every unit increase in days to positive and HIV status was significantly associated with this relationship. A cut off Ct value of 23.62 was found to best predict smear positivity regardless of HIV status. Our study findings show that GeneXpert Ct values are comparable to smear microscopy as a measure of M. tuberculosis burden and can be used to replace smear microscopy. However, given the low correlation between Xpert Ct value and culture positivity, Xpert Ct values cannot replace culture as a measure of M. tuberculosis burden among TB patients.
Sections du résumé
BACKGROUND
Determining mycobacterial burden is important in assessing severity of disease, evaluating infectiousness and predicting patient treatment outcomes. Mycobacterial burden assessed by smear microscopy grade and time to culture positivity is clearly interpretable by most physicians. GeneXpert (Xpert) has been recommended by WHO as a first line tuberculosis (TB) diagnostic test as an alternative to smear microscopy. Xpert gives cycle threshold (Ct) values as a potential measure for mycobacterial burden. For physicians to clearly interpret Ct values as measures of mycobacterial burden, this study compared the Xpert quantification capabilities with those of smear microscopy and culture. The study also determined a linear relationship between Xpert Ct values and MGIT culture time to positivity (MGIT-TTP) and associated factors. A cut off Ct value which best predicts smear positivity was also determined using the Receiver Operator Curve analysis method.
RESULTS
Excluding missing results and rifampicin resistant TB cases, a moderately strong correlation of 0.55 between Xpert Ct value and smear grade was obtained. A weak correlation of 0.37 was obtained between Xpert Ct values and MGIT time to positivity while that between Xpert Ct values and LJ culture was 0.34. The Xpert Ct values were found to increase by 2.57 for every unit increase in days to positive and HIV status was significantly associated with this relationship. A cut off Ct value of 23.62 was found to best predict smear positivity regardless of HIV status.
CONCLUSION
Our study findings show that GeneXpert Ct values are comparable to smear microscopy as a measure of M. tuberculosis burden and can be used to replace smear microscopy. However, given the low correlation between Xpert Ct value and culture positivity, Xpert Ct values cannot replace culture as a measure of M. tuberculosis burden among TB patients.
Identifiants
pubmed: 31091275
doi: 10.1371/journal.pone.0216901
pii: PONE-D-19-02137
pmc: PMC6519814
doi:
Types de publication
Clinical Trial
Comparative Study
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216901Subventions
Organisme : FIC NIH HHS
ID : D43 TW009607
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2010 Sep 9;363(11):1005-15
pubmed: 20825313
Am J Respir Crit Care Med. 2014 Jun 1;189(11):1426-34
pubmed: 24786895
Am J Respir Crit Care Med. 2011 Jul 1;184(1):132-40
pubmed: 21493734
PLoS One. 2013 Sep 04;8(9):e72470
pubmed: 24023742
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1076-84
pubmed: 21836139
PLoS One. 2016 Sep 09;11(9):e0162833
pubmed: 27611466
BMC Public Health. 2015 Jul 29;15:721
pubmed: 26220804
Indian J Tuberc. 2018 Oct;65(4):296-302
pubmed: 30522616
Sci Rep. 2018 Mar 26;8(1):5201
pubmed: 29581435
PLoS One. 2013 Oct 29;8(10):e77456
pubmed: 24204834
Int J Tuberc Lung Dis. 2010 Dec;14(12):1596-602
pubmed: 21144246
Curr HIV/AIDS Rep. 2013 Sep;10(3):264-72
pubmed: 23824469
BMC Public Health. 2015 Jan 21;15:13
pubmed: 25604986
BMC Public Health. 2005 Nov 24;5:122
pubmed: 16307685